uc001kqn.3_intron_5_0_chr10_101934039

TTCGTTCCTTAATTTCTTTATTAGATAATTCCTTGCAATTTTTTTCCCACACAAAAGGGAAGAAAAGGCAGTTTAAGCTCTGTAAAAGAATAGTACTGTGGAAACTTTAGGTCTAATAATGATTAGTTTTGTTTCATTATGAATACAATGTAAAAAAAATTGACTATCATGAGATCTGTTGTTCTTGGCTTAAAAAACAGATCAAATAGATGAAAACCTGAAGCAAGCTCTGCAGAAAGACTTAAACCTC
.......................................................................((((((((......(((((((.....((....))..(((((((....((((((((((((.(((((((........)))).))).))))))))...)))).))))))).)))))))))))))))........................................................
..................................................51...................................................................................................................................................200................................................

Size

Perfect hit

Total Norm

Perfect Norm

SRR207110(GSM721072)
Nuclear RNA. (cell line)

SRR553576(SRX182782)
source: Testis. (testes)

SRR039622(GSM531985)
HCV(+) Adjacent Tissue Sample. (liver)

SRR039623(GSM531986)
HCV(+) HCC Tissue Sample. (liver)

DRR000555(DRX000313)
"THP-1 whole cell RNA, no treatment". (cell line)

DRR000558(DRX000316)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)

SRR189781(GSM714641)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)

SRR330889(SRX091727)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR330887(SRX091725)
tissue: skin psoriatic uninvolveddisease stat. (skin)

DRR000556(DRX000314)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)

SRR326279(GSM769509)
cytoplasmic fraction was isolated using PARIS. (cell line)

TAX577741(Rovira)
total RNA. (breast)

SRR330861(SRX091699)
tissue: skin psoriatic involveddisease state:. (skin)

SRR207115(GSM721077)
XRN1&2 knockdown. (XRN1/XRN2 cell line)

SRR330902(SRX091740)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR330915(SRX091753)
tissue: normal skindisease state: normal. (skin)

SRR326280(GSM769510)
total cell content of unperturbed cells was s. (cell line)

SRR326281(GSM769511)
"Dicer mRNA was knocked down using siDicer, c. (cell line)

RoviraIPAgo2(Rovira)
total RNA. (ago2 breast)

SRR330867(SRX091705)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330921(SRX091759)
tissue: normal skindisease state: normal. (skin)

SRR330872(SRX091710)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330865(SRX091703)
tissue: skin psoriatic involveddisease state:. (skin)

SRR189784

SRR330873(SRX091711)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330908(SRX091746)
tissue: normal skindisease state: normal. (skin)

SRR330888(SRX091726)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR553572(SRX182778)
source: Frontal Cortex. (Frontal Cortex)

SRR330864(SRX091702)
tissue: skin psoriatic involveddisease state:. (skin)

GSM532874(GSM532874)
G699T. (cervix)

SRR330923(SRX091761)
tissue: normal skindisease state: normal. (skin)

SRR033721(GSM497066)
Ly3 cell line (Ly3). (B cell)

SRR029128(GSM416757)
H520. (cell line)

SRR330884(SRX091722)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR189779(GSM714639)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)

SRR330896(SRX091734)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR330899(SRX091737)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR033715(GSM497060)
Mantle Cell Lymphoma (Mino122). (B cell)

SRR330874(SRX091712)
tissue: skin psoriatic involveddisease state:. (skin)

DRR001489(DRX001043)
"Hela short nuclear cell fraction, control". (hela)

SRR330868(SRX091706)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330877(SRX091715)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330858(SRX091696)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330869(SRX091707)
tissue: skin psoriatic involveddisease state:. (skin)

SRR326282(GSM769512)
"Dicer mRNA was knocked down using siDicer, t. (cell line)

GSM450605(GSM450605)
miRNA sequencing raw reads from post-mortem s. (brain)

SRR330878(SRX091716)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330916(SRX091754)
tissue: normal skindisease state: normal. (skin)

GSM450598(GSM450598)
miRNA sequencing raw reads from post-mortem s. (brain)

SRR343337

SRR039624(GSM531987)
HBV(-) HCV(-) Adjacent Tissue Sample. (liver)

SRR189778(GSM714638)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)

.....................................................................................................................................................................................TTCTTGGCTTAAAAAACAG..................................................

25.00

9.00

2.00

3.00

2.00

1.00

2.00

1.00

....................................................................................................................................................................................GTTCTTGGCTTAAAAAACAG..................................................

17.00

1.00

2.00

1.00

2.00

1.00

...................................................................................................................................................................................TGTTCTTGGCTTAAAAAACAG..................................................

9.00

2.00

1.00

...................................................................................................................................................................................................................GAAAACCTGAAGCAAGCTCTGCAGAAAGAC.........

2.00

1.00

...................................................................................................................................................................................................................GAAAACCTGAAGCAAGCT.....................

2.00

1.00

..............................................................................................................................................................................................................TAGATGAAAACCTGAAGCAAGCTC....................

2.00

....................................................................................................................................................................................GTTCTTGGCTTAAAAAACA...................................................

2.00

1.00

..............................................................................................................................................................................................................TAGATGAAAACCTGAAGCAAGCTCTG..................

1.00

...................................................................................................................................................................................................................GAAAACCTGAAGCAAGCTCTGC.................

1.00

...............................................................................................................................................................................CTGTTGTTCTTGGCTTAAAAAACAG..................................................

1.00

................................................................................................................................................................................................................................AAGCTCTGCAGAAAGACTTA......

1.00

..............................................................................................................................................................................................................TAGATGAAAACCTGAAGCAAGCTCTGCAGA..............

1.00

...................................................................................................................................................................................................................GAAAACCTGAAGCAAGCTCTGCAGAAAG...........

1.00

..................................................ACAAAAGGGAAGAAAAAACA....................................................................................................................................................................................

1.00

0.00

1.00

..........................................................................................................................................................................................................CAAATAGATGAAAACCTGAAGCAAGCTCTG..................

1.00

.................................................................................................................................................................................................................................AGCTCTGCAGAAAGACTTA......

1.00

.....TCCTTAATTTCTTTATTATCTT...............................................................................................................................................................................................................................

1.00

0.00

1.00

.......................................................AGGGAAGAAAAGGCAGCTGT...............................................................................................................................................................................

1.00

0.00

1.00

................................................................................................................................................................................................................GATGAAAACCTGAAGCAAGCTCTTCA................

1.00

0.00

1.00

..........................................................................................TAGTACTGTGGAAACTCTG.............................................................................................................................................

1.00

0.00

1.00

....................................................................................................................................................................................................................AAAACCTGAAGCAAGCTCTGCAGATA............

1.00

0.00

1.00

............................................................................................................................................................................................................AATAGATGAAAACCTGAAGCAAGCTCT...................

1.00

..............................................................................................................................................................................................................TAGATGAAAACCTGAAGCAAGCTCTGC.................

1.00

.............................................................................................................................................................................................................ATAGATGAAAACCTGAAGCAAGCTC....................

1.00

.................................................................................................................................................................................................................ATGAAAACCTGAAGCAAGCTCTGCAGA..............

1.00

......................................................................................................................................................................................................................AACCTGAAGCAAGCTGCAG.................

1.00

0.00

1.00

............................................................................................................................................................................................................AATAGATGAAAACCTGAAGCAAGC......................

1.00

..........................................................................................................................................................................................................CAAATAGATGAAAACCTGAAGCAAGCTCTGCAGAAA............

1.00

......................................................................................................................................................................................................................AACCTGAAGCAAGCTCTG..................

1.00

....................................................................................................................................................................................................................AAAACCTGAAGCAAGCTCT...................

1.00

............................................................................................................................................................................................................AATAGATGAAAACCTGAAGCA.........................

1.00

..................................................................................................................................................................................................................TGAAAACCTGAAGCAAGCTCTGC.................

1.00

....................................................................................................................................................................................................................AAAACCTGAAGCAAGCTCTGCAGAAA............

1.00

................................................................................................................................................................................................................................AAGCTCTGCAGAAAGACTT.......

1.00

TTCGTTCCTTAATTTCTTTATTAGATAATTCCTTGCAATTTTTTTCCCACACAAAAGGGAAGAAAAGGCAGTTTAAGCTCTGTAAAAGAATAGTACTGTGGAAACTTTAGGTCTAATAATGATTAGTTTTGTTTCATTATGAATACAATGTAAAAAAAATTGACTATCATGAGATCTGTTGTTCTTGGCTTAAAAAACAGATCAAATAGATGAAAACCTGAAGCAAGCTCTGCAGAAAGACTTAAACCTC .......................................................................((((((((......(((((((.....((....))..(((((((....((((((((((((.(((((((........)))).))).))))))))...)))).))))))).)))))))))))))))........................................................ ..................................................51...................................................................................................................................................200................................................	Size	Perfect hit	Total Norm	Perfect Norm	SRR207110(GSM721072) Nuclear RNA. (cell line)	SRR553576(SRX182782) source: Testis. (testes)	SRR039622(GSM531985) HCV(+) Adjacent Tissue Sample. (liver)	SRR039623(GSM531986) HCV(+) HCC Tissue Sample. (liver)	DRR000555(DRX000313) "THP-1 whole cell RNA, no treatment". (cell line)	DRR000558(DRX000316) "THP-1 whole cell RNA, after 3 day treatment . (cell line)	SRR189781(GSM714641) cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)	SRR330889(SRX091727) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR330887(SRX091725) tissue: skin psoriatic uninvolveddisease stat. (skin)	DRR000556(DRX000314) "THP-1 whole cell RNA, after 3 day treatment . (cell line)	SRR326279(GSM769509) cytoplasmic fraction was isolated using PARIS. (cell line)	TAX577741(Rovira) total RNA. (breast)	SRR330861(SRX091699) tissue: skin psoriatic involveddisease state:. (skin)	SRR207115(GSM721077) XRN1&2 knockdown. (XRN1/XRN2 cell line)	SRR330902(SRX091740) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR330915(SRX091753) tissue: normal skindisease state: normal. (skin)	SRR326280(GSM769510) total cell content of unperturbed cells was s. (cell line)	SRR326281(GSM769511) "Dicer mRNA was knocked down using siDicer, c. (cell line)	RoviraIPAgo2(Rovira) total RNA. (ago2 breast)	SRR330867(SRX091705) tissue: skin psoriatic involveddisease state:. (skin)	SRR330921(SRX091759) tissue: normal skindisease state: normal. (skin)	SRR330872(SRX091710) tissue: skin psoriatic involveddisease state:. (skin)	SRR330865(SRX091703) tissue: skin psoriatic involveddisease state:. (skin)	SRR189784	SRR330873(SRX091711) tissue: skin psoriatic involveddisease state:. (skin)	SRR330908(SRX091746) tissue: normal skindisease state: normal. (skin)	SRR330888(SRX091726) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR553572(SRX182778) source: Frontal Cortex. (Frontal Cortex)	SRR330864(SRX091702) tissue: skin psoriatic involveddisease state:. (skin)	GSM532874(GSM532874) G699T. (cervix)	SRR330923(SRX091761) tissue: normal skindisease state: normal. (skin)	SRR033721(GSM497066) Ly3 cell line (Ly3). (B cell)	SRR029128(GSM416757) H520. (cell line)	SRR330884(SRX091722) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR189779(GSM714639) cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)	SRR330896(SRX091734) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR330899(SRX091737) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR033715(GSM497060) Mantle Cell Lymphoma (Mino122). (B cell)	SRR330874(SRX091712) tissue: skin psoriatic involveddisease state:. (skin)	DRR001489(DRX001043) "Hela short nuclear cell fraction, control". (hela)	SRR330868(SRX091706) tissue: skin psoriatic involveddisease state:. (skin)	SRR330877(SRX091715) tissue: skin psoriatic involveddisease state:. (skin)	SRR330858(SRX091696) tissue: skin psoriatic involveddisease state:. (skin)	SRR330869(SRX091707) tissue: skin psoriatic involveddisease state:. (skin)	SRR326282(GSM769512) "Dicer mRNA was knocked down using siDicer, t. (cell line)	GSM450605(GSM450605) miRNA sequencing raw reads from post-mortem s. (brain)	SRR330878(SRX091716) tissue: skin psoriatic involveddisease state:. (skin)	SRR330916(SRX091754) tissue: normal skindisease state: normal. (skin)	GSM450598(GSM450598) miRNA sequencing raw reads from post-mortem s. (brain)	SRR343337	SRR039624(GSM531987) HBV(-) HCV(-) Adjacent Tissue Sample. (liver)	SRR189778(GSM714638) cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
....TTCCTTAATTTCTTTGGGT...................................................................................................................................................................................................................................	19		2.00	0.00	-	-	-	-	-	-	-	-	-	-	1.00	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
..................................................................................................................................................................................................AAACAGATCAAATAGACT......................................	18		1.00	0.00	-	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
....TTCCTTAATTTCTTTAGGT...................................................................................................................................................................................................................................	19		1.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
....TTCCTTAATTTCTTTAGG....................................................................................................................................................................................................................................	18		1.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
..................................................................................................................AATAATGATTAGTTTTGTT.....................................................................................................................	19		1.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
.......................................................................................................................................................AAAAAAAATTGACTATCCC................................................................................	19		1.00	0.00	-	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
..................................................................................................................................................AATGTAAAAAAAATTAATC.....................................................................................	19		1.00	0.00	-	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
...................................................CCTTTTCTTCCCTTTTG......................................................................................................................................................................................	17	8	0.12	0.12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.12